Full Press Release Details
Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Your vote is important no
matter how many shares you own. Vote today.
Shareholders who have questions
or need assistance with voting their shares should contact Aurora Cannabis Inc.'s strategic advisor and proxy solicitation agent, Laurel
Hill Advisory Group, by telephone at 1-877-452-7184 or by email at assistance@laurelhill.com.
19, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company
opening the world to cannabis, is pleased to announce its notice of annual general meeting of shareholders and management information
circular (the "Circular") are now available on the Company's website at www.auroramj.com/investors/corporate-governance as
well as under Aurora's profile on SEDAR (www.sedar.com). The Company has mailed the Circular and related materials for the annual general
meeting to Aurora's shareholders.
Shareholder Meeting Details
Aurora's annual general
meeting of shareholders (the "Meeting") will be held virtually on Monday August 14, 2023 at 1:00 p.m. (Eastern time)
and the virtual meeting will be conducted via live webcast at: http://meetnow.global/MDU47WN. The virtual meeting format will allow shareholders
and duly appointed proxyholders to have an equal opportunity to participate at the Meeting and vote on the matters considered at the
Meeting, regardless of geographic location or ownership. Detailed instructions about how to participate in the Meeting can be found in
the Circular. The Circular also provides details of the proposals Aurora's shareholders will vote on at the Meeting.
board of directors recommends that shareholders vote FOR all of the director nominees and meeting resolutions.
are encouraged to read the Circular and vote your shares as soon as possible. The deadline for voting your shares is at 1:00 p.m. (Eastern
time) on Thursday August 10, 2023.
VOTE IS IMPORTANT. VOTE YOUR SHARES FOR AURORA'S DIRECTOR NOMINEES AND MEETING RESOLUTIONS AS SOON AS POSSIBLE
Shareholder Questions
Shareholders who have
any questions or require assistance with voting may contact the Aurora's proxy solicitation agent and shareholder communications advisor:
Laurel Hill Advisory
Toll Free: 1-877-452-7184 (for shareholders in North America)
International: +1 416-304-0211 (for shareholders outside Canada and the US)
By Email: assistance@laurelhill.com
Aurora is opening the
world to cannabis, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global
cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Medical
cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios,
Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of
propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands
continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are
on the NASDAQ and TSX under the symbol "ACB".
Aurora's common shares
trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes
statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking
statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or statements that certain events or conditions "may"
or "will" occur. Forward-looking statements made in this news release include statements regarding the Company's upcoming annual
These forward-looking
statements are only predictions. Forward looking information or statements contained in this news release have been developed based on
assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis
and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements
are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances
could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel,
the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the development of third party government and non-government consumer sales
channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations
of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that
SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of
competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in
prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics,
pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out
under the heading "Risk Factors" in the Company's annual information form dated September 30, 2022 (the "AIF")
and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed
with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks,
uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on
such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities
View original content
SOURCE Aurora Cannabis
View original content
to download multimedia: http://www.newswire.ca/en/releases/archive/July2023/19/c9352.html
For further information: For Media:
Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CNW 17:30e 19-JUL-23